Fulgent Genetics
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $83,336 | $84,069 | $81,803 | $73,463 |
Gross Profit | 32,582 | 35,512 | 34,435 | 28,346 |
EBITDA | -23,028 | -77 | -15,448 | -5,790 |
EBIT | -29,140 | -6,115 | -21,502 | -11,709 |
Net Income | -23,418 | -6,608 | -18,957 | -11,530 |
Net Change In Cash | 83,336 | 84,069 | 81,803 | 73,463 |
Free Cash Flow | -83,123 | 5,057 | -36,997 | -9,149 |
Cash | 50,193 | 117,641 | 87,880 | 67,281 |
Basic Shares | 30,777 | 30,749 | 30,832 | 30,832 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $322,671 | $283,470 | $289,213 | $618,968 |
Gross Profit | 130,875 | 107,215 | 104,456 | 366,901 |
EBITDA | -45,827 | -48,990 | -147,454 | 217,700 |
EBIT | -69,950 | -73,918 | -173,597 | 185,038 |
Net Income | -60,513 | -42,708 | -167,825 | 143,403 |
Net Change In Cash | 322,671 | 283,470 | 289,213 | 618,968 |
Free Cash Flow | -124,212 | -19,255 | 4,796 | 234,745 |
Cash | 50,193 | 55,144 | 97,473 | 79,506 |
Basic Shares | 30,777 | 30,235 | 29,784 | 30,964 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | $0.16 |
2025-09-30 | $0.14 |
2025-06-30 | -$0.62 |
2025-03-31 | $0.04 |
